Literature DB >> 2732214

Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis.

S Hara1, I Kudo, H W Chang, K Matsuta, T Miyamoto, K Inoue.   

Abstract

Extracellular phospholipase A2 was purified about 1.7 X 10(5) fold to near homogeneity from human synovial fluid of rheumatoid arthritis by sequential use of column chromatographies on heparin-Sepharose, butyl-Toyopearl, and reversed-phase HPLC. The final preparation showed a single band on SDS-polyacrylamide gel electrophoresis, and its molecular mass was estimated to be approximately 13,700 daltons. The purified enzyme had a pH optimum of 9.0 and required Ca2+ for maximum activity. It hydrolyzed phosphatidyl-ethanolamine more effectively than phosphatidylserine and phosphatidylcholine. These properties were similar to those of an extracellular phospholipase A2 detected in the peritoneal cavity of caseinate-treated rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732214     DOI: 10.1093/oxfordjournals.jbchem.a122675

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  29 in total

1.  Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Sustained activity of luteal cytosolic phospholipase A2 during luteolysis in pseudopregnant rats: its possible implication in tissue involution.

Authors:  S Kurusu; S Sakaguchi; M Kawaminami; I Hashimoto
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  CoA-independent transacylase has characteristics distinct from those of PLA2 enzymes.

Authors:  J D Winkler; C M Sung; L Huang
Journal:  Agents Actions       Date:  1991-09

4.  The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.

Authors:  Brian P Smart; Rob C Oslund; Laura A Walsh; Michael H Gelb
Journal:  J Med Chem       Date:  2006-05-18       Impact factor: 7.446

5.  Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.

Authors:  Marina Markova; Revati A Koratkar; Karen A Silverman; Vincent E Sollars; Melina MacPhee-Pellini; Rhonda Walters; Juan P Palazzo; Arthur M Buchberg; Linda D Siracusa; Steven A Farber
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

6.  Secretory phospholipase A2 induces dendritic cell maturation.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Aurélie Masurel; Sofiane Bezzine; Gérard Lambeau; Patrice André; Vincent Lotteau
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

7.  Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretion.

Authors:  Jean-Edouard Ombetta; Natacha Thelier; Chang Zhi Dong; Stéphanie Plocki; Lydia Tsagris; François Rannou; France Massicot; Atimé Djimdé; Elissar El-Hayek; Yiming Shi; Françoise Heymans; Nohad Gresh; Caroline Chauvet
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

8.  Characterization of calcium-independent cytosolic phospholipase A2 activity in the submucosal regions of rat stomach and small intestine.

Authors:  T Fukushima; G Serrero
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

9.  Differential inhibition of human secretory and cytosolic phospholipase A2.

Authors:  F Märki; W Breitenstein; E Beriger; R Bernasconi; G Caravatti; J E Francis; R Paioni; H U Wehrli; R Wiederkehr
Journal:  Agents Actions       Date:  1993-03

10.  Phospholipase A2 in human ascitic fluid. Purification, characterization and immunochemical detection.

Authors:  P T Kortesuo; T J Nevalainen
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.